Recruiting

Screening ToolTechnology-Based Intervention Pilot Testing

Sponsor:

Weill Medical College of Cornell University

Code:

NCT07146581

Conditions

Dementia

Elder Abuse

Elder Neglect

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Interventions

SIRENS

Study Details

Brief summary:

This research project has three main goals:

(1) To create a new screening tool that helps primary care doctors spot signs of neglect in older adults with dementia. (2) To design a support program that can be delivered both in person and through a mobile app on Android phones. (3) To run a clinical trial with three groups of participants to find out how effective the screening tool is on its own, and how effective it is when combined with the support program-compared to standard care.

This current phase of the project focuses on parts of goals 1 and 2, as described below.

Conditions

Dementia

Elder Abuse

Elder Neglect

Study ID

NCT07146581

Start date

Oct 16, 2026

Status verified date

Nov, 2026

Completion date

Mar 31, 2027

Anticipated

Primary completion date

Mar 31, 2027

Anticipated

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Caregiver Inclusion Criteria

21 years old or older
Provides care for a patient of Weill Cornell Medicine/NewYork-Presbyterian who meets the following criteria: (pilot only)

Patient is at least 60 years old
Patient has diagnosed dementia
Patient requires assistance with at least 1 ADL
Self-identifies as primary informal caregiver for an older adult
Provides 8 or more hours per week of direct care (may include logistics, oversight, observation, as well as hands-on care, but must include at least some in-person assistance)
Can read and speak English at a 6th grade level or above
Not blind or deaf
No active plan to disengage from providing care to the older adult within the next year
Ability to travel to the COA or CABR for study activities and/or attend study session(s) virtually through Zoom on their personal device

Caregiver Exclusion Criteria

Non-fluent English speaker
Hired caregiver
Provides care for a patient in hospice care
Too ill or weak to complete the interviews (per the interviewer)

Study Design

Enrollment

40 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Experimental: SIRENS Intervention

The SIRENS intervention is a technology intervention designed specifically for caregivers of those with dementia, providing them with easy access to expert-reviewed information and helpful resources. The content includes take-home messages summarizing the main points discussed and a goal-setting feature that encourages the care givers to establish small, actionable goals.

Interventions

SIRENS

Primary outcome measure

Perceived system feasibility, acceptability, and usability of the SIRENS intervention as measured by the Mean Difference in Score of the Program Evaluation Questionnaire. [ Time Frame: 1 week post-intervention ]
Perceived system feasibility, acceptability, and usability of the SIRENS intervention as measured by a qualitative interview assessment [ Time Frame: 1-week post intervention ]

Central Contacts and Locations

Central contacts

Chelsie Burchett, PhD

6469627141 cob2014@med.cornell.edu

Sophie Park

sep4008@med.cornell.edu

Locations

Weill Cornell Medicine

Recruiting

New York, New York, United States, 10065

Contacts

Chelsie Burchett, PhD

646-962-7141 cob2014@med.cornell.edu

Principal Investigator:

Anthony Rosen, MD

More Information

Sponsor

Weill Medical College of Cornell University

Last update posted

Nov 6, 2026

Last verified

Nov, 2026

Keywords

Older Adults
Technology

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-07. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-11-06. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.